A Phase I Study to Determine the Safety of Imatinib in Combination With PTK787/ZK222584 in Patients With Refractory and/or Advanced Solid Tumours.
Phase of Trial: Phase I
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Imatinib; Vatalanib
- Indications Solid tumours
- Focus Adverse reactions
- 28 Apr 2011 Planned End Date changed from 1 Jan 2009 to 1 Jun 2011 as reported by ClinicalTrials.gov.
- 01 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Mar 2008 New trial record.